JM Midcap Fund
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. There is no assurance that the investment objective of the Scheme will be realized.
Growthvine rating: 3/5 — ranked #13 of 33 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹21.58 (as of 2026-08-21) |
|---|
| AUM | ₹1,275 Cr |
|---|
| Expense ratio | 1.85% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Satish Ramanathan |
|---|
| Exit load | 1% for redemption within 180 days |
|---|
Performance & risk
| Sharpe ratio | 0.71 |
|---|
| Standard deviation | 18.93% |
|---|
| Max drawdown | -23.08% |
|---|
| Alpha | 0.95 |
|---|
| Beta | 1.01 |
|---|
Over 5 years, captured 102.2% of NIFTY Midcap 150's upside and 94.0% of its downside.
Market cap allocation
| Large cap | 5.1% |
|---|
| Mid cap | 69.9% |
|---|
| Small cap | 25.0% |
|---|
Concentration
| Top 5 holdings | 15.7% |
|---|
| Top 10 holdings | 28.9% |
|---|
| Total holdings | 68 |
|---|
| Index overlap | 36.6% |
|---|
| Active share | 63.4% |
|---|
Top holdings
- Bharat Forge Ltd — 3.6%
- Godfrey Phillips India Ltd. — 3.2%
- Marico Limited — 3.1%
- IDFC FIRST BANK LIMITED — 3.0%
- One 97 Communications Limited — 2.9%
- Bank of maharashtra — 2.8%
- Avalon Technologies Limited — 2.8%
- Tube Investments of India Ltd — 2.8%
- Glenmark Pharmaceuticals ltd — 2.4%
- ACUTAAS CHEMICALS LIMITED — 2.4%
Top sectors
- Banking & Financial — 16.1%
- Pharma & Biotech — 12.4%
- Automobile — 12.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 13.6% | Q1 (Top) | #2 of 31 |
| 2025 | -2.7% | Q4 (Bottom) | #26 of 29 |
| 2024 | 35.3% | Q1 (Top) | #5 of 29 |
| 2023 | 44.5% | Q1 (Top) | #3 of 28 |